PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZIL

被引:0
|
作者
Machado, M. [1 ]
Canella, M. [1 ]
Franco, E. [1 ]
Zajdenverg, R. [1 ]
机构
[1] GlaxoSmithKline Brazil, Rio De Janeiro, Brazil
关键词
D O I
10.1016/j.jval.2011.02.663
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A119 / A119
页数:1
相关论文
共 50 条
  • [21] Cost effectiveness of tipranavir in treatment-experienced HIV patients in the USA
    Simpson, KN
    Chumney, ECG
    Hicks, CB
    Finnern, H
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A156 - A156
  • [22] COST-MINIMIZATION ANALYSIS OF MARAVIROC VERSUS DARUNAVIR RALTEGRAVIR AND ENFUVIRTIDE FOR CCR5-TROPIC TREATMENT-EXPERIENCED PATIENTS WITH HIV INFECTION IN RUSSIA
    Pyadushkina, E.
    Omelyanovsky, V
    Avxentyeva, M.
    Rebrova, O.
    Goryaynov, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A358 - A359
  • [23] Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies
    Jacqmin, P.
    Wade, J. R.
    Weatherley, B.
    Snoeck, E.
    Marshall, S.
    McFadyen, L.
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (08):
  • [24] Clinical experience with maraviroc (UK 427857 or Celsentri®) with an optimized background regimen in highly treatment-experienced patients
    Teague, A.
    Underwood, J.
    Scott, C.
    Bower, M.
    Gazzard, B.
    Nelson, M.
    [J]. HIV MEDICINE, 2009, 10 : 18 - 18
  • [26] Alternative options for treatment-experienced people with HIV
    Slama, Laurence
    Hardy, W. David
    Quinones-Mateu, Miguel E.
    Kuritzkes, Daniel R.
    [J]. AIDS, 2023, 37 (07) : 1165 - 1166
  • [27] The management of treatment-experienced HIV patients (including virologic failure and switches)
    Cutrell, James
    Jodlowski, Tomasz
    Bedimo, Roger
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2020, 7
  • [28] Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV InfectionRationale and Results
    Babafemi Taiwo
    Robert L. Murphy
    Christine Katlama
    [J]. Drugs, 2010, 70 : 1629 - 1642
  • [29] Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy
    Hornberger, J
    Green, J
    Wintfeld, N
    Cavassini, M
    Rockstroh, A
    Giuliani, G
    De Carli, C
    Lazzarin, A
    [J]. HIV CLINICAL TRIALS, 2005, 6 (02): : 92 - 102
  • [30] Fostemsavir exposure-response relationships in treatment-experienced HIV patients
    Parasrampuria, R.
    Goyal, N.
    Moore, K.
    Ackerman, P.
    Llamoso, C.
    Barker, K.
    Magee, M.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 31 - 32